Evidence map›Paper›PMID 35684946›Full record

ArticleAnnals of clinical and translational neurology2022

Biallelic loss of EMC10 leads to mild to severe intellectual disability.

Rauan Kaiyrzhanov, Clarissa Rocca, Mohnish Suri, Sughra Gulieva, Maha S Zaki, Noa Z Henig, Karine Siquier, Ulviyya Guliyeva, Samir M Mounir, Daphna Marom and 15 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 16 institutions in 10 countries.

Rauan KaiyrzhanovDepartment of Neuromuscular Disorders, Queen Square Institute of Neurology, University College London, London, UK.ORCID 0000-0003-1640-4010
Clarissa RoccaDepartment of Neuromuscular Disorders, Queen Square Institute of Neurology, University College London, London, UK.ORCID 0000-0003-3233-5529
Mohnish SuriClinical Genetics Service, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Sughra GulievaMediClub Hospital, 45, Uzeyir Hajibeyli str., Baku, AZ1010, Azerbaijan.
Maha S ZakiHuman Genetics and Genome Research Division, Clinical Genetics Department, National Research Centre, Cairo, Egypt.
Noa Z HenigGenetics Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Karine SiquierDevelopmental Brain Disorders Laboratory, Imagine Institute, INSERM UMR, Université Paris Cité, Paris, France.
Ulviyya GuliyevaMediClub Hospital, 45, Uzeyir Hajibeyli str., Baku, AZ1010, Azerbaijan.
Samir M MounirPediatrics Department, Faculty of Medicine, El-Minia University, Minia, Egypt.
Daphna MaromGenetics Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Aynur AllahverdiyevaChild Neurology Hospital, Taghi Shahbazi str., Baku, AZ1065, Azerbaijan.
Hisham MegahedClinical Genetics Department, National Research Centre, Cairo, Egypt.
Hans van BokhovenDeparment of Human Genetics, Donders Center for Brain Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands.
Vincent CantagrelDevelopmental Brain Disorders Laboratory, Imagine Institute, INSERM UMR, Université Paris Cité, Paris, France.
Aboulfazl RadDepartment of Otolaryngology, Head and Neck Surgery, Tübingen Hearing Research Centre, Eberhard Karls University, Tübingen, 72076, Germany.
Alemeh PourkeramtiMedical Biotechnology Research Center, Ashkezar University, Ashkezar, Yazd, Iran.
Boshra DehghaniMedical Biotechnology Research Center, Ashkezar University, Ashkezar, Yazd, Iran.
Diane D ShaoDepartment of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.ORCID 0000-0003-2087-4082
Keren Markus-BustaniRaphael Recanati Genetic Institute, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel.
Efrat Sofrin-DruckerSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Naama OrensteinSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Kamran SalayevDepartment of Neurology, Azerbaijan Medical University, Baku, Azerbaijan.
Filippo ArrigoniPaediatric Radiology and Neuroradiology Department, V. Buzzi Children's Hospital, Milan, Italy.
Henry HouldenDepartment of Neuromuscular Disorders, Queen Square Institute of Neurology, University College London, London, UK.
Reza MaroofianDepartment of Neuromuscular Disorders, Queen Square Institute of Neurology, University College London, London, UK.
National Hospital for Neurology and Neurosurgery · GBTel Aviv University · ILAzerbaijan Scientific-Research & Design-Prospecting Power Engineering Institute · AZBarzilai Medical Center · ILInserm · FRNational Research Centre · EGAzerbaijan Investment (Azerbaijan) · AZAzerbaijan Medical University · AZBoston Children's Hospital · USMinia University · EGNottingham University Hospitals NHS Trust · GBOspedale dei Bambini Vittore Buzzi · ITRadboud University Nijmegen · NLRafael Advanced Defense Systems (Israel) · ILTel Aviv Sourasky Medical Center · ILUniversity of Tübingen · DE

Funding

CH/BIDMC/Harvard Medical School Neurology Resident Research Education Program Competing RenewalR25NS070682 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI PODURI, ANNAPURNA, SAPER, CLIFFORD B · 2010 to 2023
$4.5M
Medical Research Council G0601943Medical Research Council MR/S005021/1Medical Research Council MR/S01165X/1NINDS NIH HHS R25 NS070682Wellcome TrustWellcome Trust 165908Wellcome Trust WT093205MAWellcome Trust WT104033AIA
6 · The paper itself

Abstract

The endoplasmic reticulum membrane protein complex subunit 10 (EMC10) is a highly conserved protein responsible for the post-translational insertion of tail-anchored membrane proteins into the endoplasmic reticulum in a defined topology. Two biallelic variants in EMC10 have previously been associated with a neurodevelopmental disorder. Utilizing exome sequencing and international data sharing we have identified 10 affected individuals from six independent families with five new biallelic loss-of-function and one previously reported recurrent EMC10 variants. This report expands the molecular and clinical spectrum of EMC10 deficiency, provides a comprehensive dysmorphological assessment and highlights an overlap between the clinical features of EMC10-and EMC1-related disease.

Indexed as

Intellectual DisabilityMembrane ProteinsNeurodevelopmental DisordersExome SequencingHumansEMC10 protein, humanMembrane Proteins

Identifiers

PMID35684946
PMCPMC9268894
OpenAlexW4281718723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.